Understanding Motivation Towards Exercise to Enhance Physical Activity on Prescription Adherence - Feasibility Study
UMEPA-F
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to explore feasibility and evaluate methods to investigate changes in physical activity, function and psychometrics in relation to an exercise intervention in physically inactive middle-aged men and women. The main questions it aims to answer are:
- Is the exercise intervention feasible regarding retention and user experience?
- Is the evaluation methods on physical activity, function and psychometrics suitable for the present study?
- Is there an intervention effect in physical activity, function and psychometrics at three and six month post baseline?
- Can barriers and facilitators towards increased physical activity be identified in the two groups of the study? All participants will first receive standard care for physically inactive patients, i.e. Physical activity on Prescription (PaP), followed by allocation to an exercise intervention (EI) group. The EI group will be offered an additional exercise intervention for 12 weeks consisting of 1-2 training sessions per week of a combination of aerobic and resistance training at a private fitness center. Feasibility of the exercise intervention will be evaluated based on retention rates and user experience. Additionally, researchers will assess physical activity, function and psychometrics in the EI group at three and six months to evaluate the suitability of the chosen methods and to get preliminary data on the intervention effect. Finally, interviews with the participants in the control and EI groups will be performed at the end of the study in order to explore barriers and facilitators towards increased physical activity in formally inactive patients. Edit after registration of the study: Due to a lower number of recruited participants than expected (20 instead of the anticipated 30), the protocol was updated by removing the control group that would initially consist of 10 participants. The remaining 20 participants were all allocated to the exercise intervention group to assess feasibility of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedStudy Start
First participant enrolled
February 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2023
CompletedApril 2, 2025
May 1, 2023
8 months
December 21, 2022
March 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence to the exercise intervention
Number of completed training sessions in the exercise intervention group
Documented continuously during the 12 week intervention period
Retention rate
The proportion of participants starting the intervention that completes outcome assessment in either group
3 months post baseline
Secondary Outcomes (10)
Time spent in moderate and vigorous physical activity
Baseline, 3 months and 6 months
Daily step-count
Baseline, 3 months and 6 months
Cardio-respiratory capacity
Baseline, 3 months and 6 months
Upper limb strength
Baseline, 3 months and 6 months
Lower limb muscle strength
Baseline, 3 months and 6 months
- +5 more secondary outcomes
Other Outcomes (2)
Feasibility of the exercise intervention
3 months
Exploring barriers and facilitators towards physical activity
6 months
Study Arms (1)
Exercise intervention
EXPERIMENTALParticipants are prescribed a Physical activity on Prescription (PaP) which means that they will have a motivational interview with a physiotherapist regarding increased physical activity. The physiotherapist will then prescribe a individualized PaP with the goal to increase weekly physical activity that the participant are instructed to adhere to for the remainder of the study. A follow-up session is also included after 12 weeks. Participants are invited to a 12 week exercise intervention at a private fitness center after they have received their PaP. The exercise, including a variety of aerobic and resistance training, is performed in a group setting starting with one session per week for the first three weeks and then two sessions per week for week 4-12. A follow-up session is also included after 12 weeks.
Interventions
The 6 month intervention consists of usual care (PaP) plus an initial 12 weeks of instructor led exercise (described below) followed by a 12 week period in where the participant will have to conduct their physical activity on their own. Exercise intervention: Participants are invited to a 12 week exercise intervention at a private fitness center after they have received their PaP. The exercise, including a variety of aerobic and resistance training, is performed in a group setting starting with one session per week for the first three weeks and then two sessions per week for week 4-12. A follow-up session is also included after 12 weeks in where a physiotherapist contact the participant and discuss how they will adhere to their Physical activity on prescription.
Eligibility Criteria
You may qualify if:
- Physically inactive persons as defined as not meeting the current recommendations of at least 150 minutes of moderate to vigorous physical activity per week. This criterion is self-assessed by potential participants.
- Age 40-60 years
You may not qualify if:
- Physical disability that affects the ability to perform the exercise intervention.
- Heart failure or severe degenerative disease, e.g. malignant cancer, multiple sclerosis etc.
- Myocardial infarction or stroke during the last 12 months.
- Heart conditions including angina pectoris that is worsened with exercise.
- Neuromuscular, musculoskeletal, or rheumatic conditions that is worsened with exercise.
- Hypertension grade III, i.e. systolic blood pressure above 180 mmHg and/or diastolic blood pressure over 110 mmHg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
Study Sites (1)
Umeå University
Umeå, Västerbotten County, SE-90187, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 20, 2023
Study Start
February 3, 2023
Primary Completion
September 29, 2023
Study Completion
September 29, 2023
Last Updated
April 2, 2025
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share
Sharing of individual data is not in accordance with the ethical permission granted from the Swedish ethics review authority.